These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1336768)

  • 21. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spending on substance abuse treatment: how much is enough?
    Meara E; Frank RG
    Addiction; 2005 Sep; 100(9):1240-8. PubMed ID: 16128713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington.
    French MT; Salomé HJ; Krupski A; McKay JR; Donovan DM; McLellan AT; Durell J
    Eval Rev; 2000 Dec; 24(6):609-34. PubMed ID: 11151519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical care utilization as a function of recovery status following chemical addictions treatment.
    Hoffmann NG; DeHart SS; Fulkerson JA
    J Addict Dis; 1993; 12(1):97-108. PubMed ID: 8381031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
    Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
    J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders.
    Dennis ML; French MT; McCollister KE; Scott CK
    J Subst Abuse Treat; 2011 Sep; 41(2):201-7. PubMed ID: 21466944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
    Goodman AC; Nishiura E; Humphreys RS
    Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic costs of Oxford House inpatient treatment and incarceration: a preliminary report.
    Olson BD; Viola J; Jason LA; Davis MI; Ferrari JR; Rabin-Belyaev O
    J Prev Interv Community; 2006; 31(1-2):63-72. PubMed ID: 16595387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of a consultation service for delivery of substance abuse services in a hospital setting.
    Barker SB; Knisely JS; Dawson KS
    J Addict Dis; 1999; 18(1):73-82. PubMed ID: 10234564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dollars and performance: treating alcohol misuse in Maine.
    Machado MP
    J Health Econ; 2001 Jul; 20(4):639-66. PubMed ID: 11463192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How many people need substance abuse treatment in North Carolina and how much does it cost?
    McCarthy P; Kissling G; Dirkers J
    N C Med J; 1993 May; 54(5):209-12. PubMed ID: 8389988
    [No Abstract]   [Full Text] [Related]  

  • 38. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.
    Cartwright WS
    Eval Rev; 1998 Oct; 22(5):609-36. PubMed ID: 10186896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women.
    French MT; McCollister KE; Cacciola J; Durell J; Stephens RL
    Subst Abus; 2002 Mar; 23(1):31-51. PubMed ID: 12444359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.